POPULARITY
5 episodes with Merryman
4 episodes with Merryman
4 episodes with Merryman
2 episodes with Merryman
3 episodes with Merryman
2 episodes with Merryman
2 episodes with Merryman
2 episodes with Merryman
2 episodes with Merryman
fWotD Episode 3209: Abraham Lincoln Welcome to featured Wiki of the Day, your daily dose of knowledge from Wikipedia's finest articles.The featured article for Monday, 16 February 2026, is Abraham Lincoln.Abraham Lincoln (February 12, 1809 – April 15, 1865) was the 16th president of the United States, serving from 1861 until his assassination in 1865. He led the United States through the American Civil War, defeating the Confederate States and playing a major role in the abolition of slavery.Lincoln was born into poverty in Kentucky and raised on the frontier. He was self-educated and became a lawyer, Illinois state legislator, and U. S. representative. Angered by the Kansas–Nebraska Act of 1854, which opened the territories to slavery, he became a leader of the new Republican Party. He reached a national audience in the 1858 Senate campaign debates against Stephen A. Douglas. Lincoln won the 1860 presidential election, becoming the first Republican president. His victory prompted a majority of the slave states to begin to secede and form the Confederate States. A month after Lincoln assumed the presidency, Confederate forces attacked Fort Sumter, starting the Civil War.As a moderate Republican, Lincoln had to navigate conflicting political opinions from contentious factions during the war effort. Lincoln closely supervised the strategy and tactics in the war effort, including the selection of generals, and implemented a naval blockade of Southern ports. He suspended the writ of habeas corpus in April 1861, an action that Chief Justice Roger Taney found unconstitutional in Ex parte Merryman, and he averted war with Britain by defusing the Trent Affair. On January 1, 1863, he issued the Emancipation Proclamation, which declared the slaves in the states "in rebellion" to be free. On November 19, 1863, he delivered the Gettysburg Address, which became one of the most famous speeches in American history. He promoted the Thirteenth Amendment to the U. S. Constitution, which, in 1865, abolished chattel slavery. Re-elected in 1864, he sought to heal the war-torn nation through Reconstruction.On April 14, 1865, five days after the Confederate surrender at Appomattox, Lincoln was attending a play at Ford's Theatre in Washington, D. C., when he was fatally shot by stage actor John Wilkes Booth, a Confederate sympathizer. Lincoln is remembered as a martyr and a national hero for his wartime leadership and for his efforts to preserve the Union and abolish slavery. He is often ranked in both popular and scholarly polls as the greatest president in American history.This recording reflects the Wikipedia text as of 00:11 UTC on Monday, 16 February 2026.For the full current version of the article, see Abraham Lincoln on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Mastodon at @wikioftheday@masto.ai.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm neural Justin.
In this clip, we're joined by Matthew Merriman, attorney for Jeffrey King, who's facing charges in a high-profile shooting case in the Northland. Matthew shares his perspective on the case, discussing the role of Missouri's stand your ground law and the importance of self-defense. He also delves into the details of the incident, including the confrontation between King and the victim, Chris Wells. With a strong defense strategy in place, Matthew explains how his firm will navigate the case and protect his client's constitutional rights. This conversation offers a unique insight into the complexities of the law and the defense's approach.See omnystudio.com/listener for privacy information.
Episode Notes We talked with Old Glory's General Manager of Rugby Operations Richard Merryman about his role on the team, how the roster came together, how the new rules affected decision-making, and got him to spill the beans on the few remaining unannounced players. About the hosts John Fitzpatrick Runs the Rugby Morning newsletter Hosts MLR Coffee Break on MLR Weekly (Rugby Wrap Up) Hosts USA Rugby Happy Hour on Twitter Spaces Twitter: @rugbymorning Alistair Kirsch-Poole Writer/editor for Glorious Rugby Runs Tackle the Numbers Twitter: @AlistairKP
Nathan (NDub) invites childhood friend and entrepreneur Dan Whiteley to chat about building a profitable niche while sharing their childhood memories. Dan shares insights from his experience running A.L. Merryman Company, a specialized executive search firm in the construction industry, and discusses the impact of AI on the sector. He also covers the challenges of affordable housing and innovative construction solutions through the Community Roots Collaborative. Guest Name: Dan Whiteley Title: Executive Recruiter & President Business: A.L. Merryman (https://merrymanco.com) LinkedIn: https://www.linkedin.com/in/constructionrecruiting/
Retiring? You could wing it...but that's not you. Be intentional about your future. Registration is now open for the next two Design Your New Life in Retirement Groups. Very Early Bird discount available for a limited time. Take the first step toward Future You today. _______________________ What if I told you the activities you dismiss as "just hobbies" were much more than just fun - and could be one of the most powerful tools for building resilience and maintaining mental sharpness as we age? Ashley Merryman reveals groundbreaking findings that challenge how we think about leisure time and its profound impact on our long-term health. From doctors now prescribing hobbies as medicine to studies finding that singing in a chorus creates instant social bonds, the science behind recreational activities is remarkable. Merryman shares fascinating research demonstrating that even modest engagement—like cooking something special twice a week—can deliver measurable cognitive benefits. Whether you're looking to boost your brain health, combat isolation, or to find more meaning in your free time, this conversation will change how you view your pastimes. Discover why hobbies aren't just fun—they're good for you, in more ways than we think. Ashley Merryman joins us from Washington, DC. _______________________ Bio Ashley Merryman is a two-time New York Times bestselling author who is a frequent contributor to US News and World Report. She who recently wrote a guest column for YOLO, a US News newsletter for retirees and those thinking about retirement on the science of hobbies - finding that hobbies are a key to a healthier, happier life. ________________________ For More on Ashley Merryman Your Hobby May Be the Secret to a Happier, Healthier Life Website _________________________ Podcast Conversations You May Like Learning is a Lifetime Sport – Tom Vanderbilt Inward Traveler – Francine Toder PhD Live Life in Crescendo – Cynthia Covey Haller _________________________ Mentioned in This Podcast Conversation Serious Leisure __________________________ About The Retirement Wisdom Podcast There are many podcasts on retirement, often hosted by financial advisors with their own financial motives, that cover the money side of the street. This podcast is different. You'll get smarter about the investment decisions you'll make about the most important asset you'll have in retirement: your time. About Retirement Wisdom I help people who are retiring, but aren't quite done yet, discover what's next and build their custom version of their next life. A meaningful retirement doesn't just happen by accident. Schedule a call today to discuss how The Designing Your Life process created by Bill Burnett & Dave Evans can help you make your life in retirement a great one – on your own terms. About Your Podcast Host Joe Casey is an executive coach who also helps people design their next life after their primary career and create their version of The Multipurpose Retirement.™ He created his own next chapter after a twenty-six-year career at Merrill Lynch, where he was Senior Vice President and Head of HR for Global Markets & Investment Banking. Today, in addition to his work with clients, Joe hosts The Retirement Wisdom Podcast, which thanks to his guests and loyal listeners, ranks in the top 1 % globally in popularity by Listen Notes, with over 1.6 million downloads. Business Insider has recognized Joe as one of 23 innovative coaches who are making a difference. He's the author of Win the Retirement Game: How to Outsmart the 9 Forces Trying to Steal Your Joy. ___________________________ Wise Quotes On the Benefits of Hobbies "The research is very clear. There have been studies, large scale studies, 20,000 people in 15 European countries, 90,000 people in another 15 or 16 countries, and they are consistently finding that hobbies lead to lower likelihood of dep...
Kolby Crawford from VT Scoop and 247Sports.com joins Pete and Sam to break down all the latest news coming out of Hokies Spring Practice. With the Spring Game just days away, the boys ask the tough questions about QB1 and get progress updates at every position. There are so many new faces it's created a bit of a different feel around Merryman... though, it's still unclear whether the vibe change will lead to results this fall.
How are you helping to crack open hearts and mend the frayed community we live in? In this episode, Jeff and Kelly discuss: Kelly's transformational experience in South Africa in her early 20s. The beauty of meeting new people and learning from them. Identifying your superpower. The need for engaging, values-based entertainment and programming. Key Takeaways: We are all different. If you are curious and kind, you can always find something that connects you to someone else. One of the biggest risks to success and happiness is allowing the day to take us through without spending our time intentionally.Be willing to take risks. Ask yourself at every juncture, do I want to go left or right? It will free you from the machine. God's time and path may not be what we expect, but it is guided by Him. Only in retrospect can we see that path. "Our job is not to preach. Our job is to crack open hearts. And you crack open hearts with high emotional stakes, with the realization that people can find themselves and their stories on the screen." — Kelly Merryman Hoogstraten Episode References: The Spiritual Art of Business by Barry L. Rowan: amazon.com/Spiritual-Art-Business-Connecting-Divine/dp/1514007622House of David - Coming February 27, 2025: https://www.primevideo.com/detail/House-of-David/0PGUBDIDXTNZZ0JDLMRZWK608MWall Street Journal: Religious Movies Are Sweeping Hollywood. Rich Investors Are Pouring In Millions. By John Jurgensen - https://www.wsj.com/style/house-of-david-jon-erwin-wonder-project-angel-studios-d31ac703 About Kelly Merryman Hoogstraten, Chief Executive Officer, Wonder Project:For the last 20 years, Kelly has been at the forefront of innovation in digital media and technology, holding senior leadership roles at Netflix, YouTube, and Aura.Most recently, Kelly was President & COO at Aura where she spearheaded the company's product and go-to-market strategy and oversaw the product, sales, marketing, and operations teams. From 2015-2021 Kelly served as Vice President of Content Partnerships at YouTube, where she led the global partnership strategy and management of content creators and media companies across the Americas. Prior to YouTube, Kelly was Vice President of content Acquisition at Netflix from 2007 to 2014, driving the company's international expansion across markets in Western Europe, Canada, and Latin America. Kelly also held positions at Sony Pictures, Bain & Company, and Audax Group. Connect with Kelly Merryman Hoogstraten:Website: https://www.thewonderproject.com/ LinkedIn: https://www.linkedin.com/in/kellymerryman/ Connect with Jeff Thomas: Website: https://www.arkosglobal.com/Podcast: https://www.generousbusinessowner.com/Book: https://www.arkosglobal.com/trading-upEmail: jeff.thomas@arkosglobal.comTwitter: https://twitter.com/ArkosGlobalAdv Facebook: https://www.facebook.com/arkosglobal/LinkedIn: https://www.linkedin.com/company/arkosglobaladvisorsInstagram: https://www.instagram.com/arkosglobaladvisors/YouTube: https://www.youtube.com/channel/UCLUYpPwkHH7JrP6PrbHeBxw
Kadidia Dienta joins Gresh and Fauria along with Dr. Reid Merryman. Kadidia discusses her battle with lymphoma cancer that begin in July 2020. Kadidia's treatment included chemotherapy, CAR T therapy, and after two relapses with cancer, she is currently participating in a clinical trial that shows promise. Dr. Merryman is an attending physician in the Lymphoma Program at Dana-Farber Cancer Institute. His research focuses on the development of immune-based therapies for patients with lymphoma.
On the Aug. 9 Friday LIVE at Nebraska Public Media, host Genevieve Randall and guests have lively conversations about: "The Cabin: Catharsis in The Pandemic" from mixed media painter Raul Alejandro; Merryman Center's new season "The Jan Collective" by artist Jan Fox; Water Street Dance Milwaukee in Holdrege; Cyrus Jaffery's new memoir; and Colby Coash's new book and event. Also, some poetry from Sarah McKinstry-Brown from and a preview of Omaha Fringe Festival's “Of Darkness and Dreams.”
On the Aug. 9 Friday LIVE at Nebraska Public Media, host Genevieve Randall and guests have lively conversations about: "The Cabin: Catharsis in The Pandemic" from mixed media painter Raul Alejandro; Merryman Center's new season "The Jan Collective" by artist Jan Fox; Water Street Dance Milwaukee in Holdrege; Cyrus Jaffery's new memoir; and Colby Coash's new book and event. Also, some poetry from Sarah McKinstry-Brown from and a preview of Omaha Fringe Festival's “Of Darkness and Dreams.”
Send us a Text Message.What happens when you step out of your comfort zone and embrace the unknown? Join us on a magical journey to Sedona, where Christy recounts her transformative experience at a women's retreat. Initially wrestling with skepticism and the desire for familiar faces, she soon discovered the joy of unexpected connections through carpooling with fellow participants. This episode highlights her drive into Sedona, where the stunning transition from cactus-filled landscapes to mesmerizing red rocks marked the beginning of an unforgettable adventure.From setting intentions to forming deep connections with oneself and others, this retreat was a profound exploration of personal growth and self-acceptance. We discuss overcoming past hurts from female friendships and the courage it takes to engage with strangers. Highlights include my first sound bath, Reiki healing session, and drawing a tarot card that brought an unexpected toad into the picture. These experiences underscore the importance of embracing discomfort and pushing through old people-pleasing tendencies.But the journey didn't stop there. Spiritual synchronicity played a significant role, from the symbolic significance of toads to a challenging hike up Cathedral Rock. Each step and struggle led to immense physical and spiritual rewards. Christy's session with the psychic Merryman provided deep insights through her astrological birth chart and vivid imagery from her Akashic records. This episode captures the essence of being present, pushing through challenges, and embracing the universe's messages, ultimately leading to a lighter, more connected self.Medical Disclaimer Have questions or comments for A Witch, A Mystic & A Feminist? Send us a message at https://www.wmfpod.com/contact/. Also you can subscribe to receive updates at https://www.wmfpod.com.
As finals wrap up across the country, we are reaching the slowest part of the offseason. Nevertheless, Pete and Sam are back to get you up to date on all the latest from Hahn Hurst, Merryman, English Field, etc. After hitting all the sports, the guys discuss Sam's personal ACC power rankings.
This episode looks at “Law Films You Won't Want to Miss,” a recent list of "the most captivating legal themed movies," published in U.S. News and World Report. Which movies are on the list? Which didn't make the cut? And what does the list tell us about “law movies”—and of great law movies? One film on the list may be something of a surprise: Miracle on 34th Street (1947) written and directed by George Seaton, from a story by Valentine Davies. In this Christmas holiday classic, the events director of Macy's Department Store in NYC, Doris Walker (Maureen O'Hara) hires an old man named Kris Kringle (Edmund Gwenn, who won an Oscar as best supporting actor) to serve as Macy's Santa Clause after the prior Santa is fired for being a drunk. Kringle not only closely resembles Santa Clause but believes he is Santa. Kringle is welcomed into Doris's home and makes a favorable impression on Doris's daughter Susan (Natalie Wood). Kringle also makes an impression at work. He advises one customer to go to another store when Macy's can't fulfill her son's request for a particular toy instead of trying to sell her something else. This turns out to be a public relations stroke of genius, demonstrating Macy's concern for and loyalty to its customers. But Kringle's success at Macy's doesn't last. He gets into a dispute with another employee who insists Kringle be fired and put into a mental hospital. A civil commitment hearing takes place, where the question centers on whether Kringle's belief that he is Santa Clause shows he is insane. Miracle on 34th Street raises timeless questions how law should treat beliefs. I'm joined by Ashley Merryman, the author of the list, “Law Films You Won't Want to Miss.”Timestamps:0:00 Introduction4:21 The top law movies5:16 What makes a great law movie9:19 Witness for the Prosecution and other favorites16:16 Erin Brockovich and why great law movies aren't always courtroom dramas22:54 Some also-rans29:45 Why Miracle on 34th Street made the list31:53 A take on how politics informs courts and trials35:34 Proving Santa Claus through a federal postal regulation39:47 The legal realism of Miracle on 34th Street41:40 When holiday movies were released in the spring45:34 When courts are the arbiter of beliefs 51:04 Fun facts in compiling the best law movies list57:29 Introducing the new Q & A segmentFurther reading:Davis, Kevin, "The 25 Greatest Legal Movies: Expanding the Boundaries," ABA Journal (Aug. 2018) Merryman, Ashley, “Law Films You Won't Want to Miss,” U.S. News & World Report (Feb. 1, 2024)Minnow, Nell, “An Idea Is a Greater Monument than a Cathedral: Deciding How We Know What We Know in ‘Inherit the Wind,'” 30 U.S.F. L. Rev. 1225 (1996) Olear, Greg, “‘Miracle on 34th Street': Best Christmas movie ever,”? Salon (Dec. 24, 2012) Law on Film is created and produced by Jonathan Hafetz. Jonathan is a professor at Seton Hall Law School. He has written many books and articles about the law. He has litigated important cases to protect civil liberties and human rights while working at the ACLU and other organizations. Jonathan is a huge film buff and has been watching, studying, and talking about movies for as long as he can remember. For more information about Jonathan, here's a link to his bio: https://law.shu.edu/faculty/full-time/jonathan-hafetz.cfmYou can contact him at jonathanhafetz@gmail.comYou can follow him on X (Twitter) @jonathanhafetz You can follow the podcast on X (Twitter) @LawOnFilmYou can follow the podcast on Instagram @lawonfilmpodcast
This week we welcome back our good friend Coach Robbie Compton. Fresh off his trip to Blacksburg for the annual coaches clinic and chalk talk, he fills us in on the areas of emphasis for the clinic, his impressions of the buzz around Merryman, and his takeaways about the 2024 squad based on the live practices and practice tape he's been able to review.
Introduction by Todd HovermaleJoin host Jeff Klopfenstein and guest Chad Merryman, Chief Commercial Officer with Watlow as they discuss the recent growth of the thermal product manufacturer. Approaching 19 years with Watlow, Chief Commercial Officer, Chad Merryman has a proven track record in driving revenue growth through exceptional strategy development and clarity, channel execution with mastery of process and technique, and commercial leadership across sales, product management, and marketing. Visit Guest Chad Merryman's LinkedIn
Football season is behind us, but there's still plenty going on over in Merryman at the start of Spring semester. Pete and Sam fill you in on all the latest roster news before providing updates for both the men's and women's basketball teams. Finally, the 2024 Virginia Tech football schedule is out! The guys react to each and every week and what it could mean for the Hokies. Learn more about your ad choices. Visit megaphone.fm/adchoices
https://www.thebereancall.org/content/t-mcmahon-ron-merryman-part-2More topics on our website: https://www.thebereancall.org/topicsFree eBooks: https://davehunt.orgDownload our app: https://www.thebereancall.org/appFollow us on Social Media: https://www.thebereancall.org/socialTom: Thanks, Gary. Today, my guest is Ron Merryman. Ron is an author, former Bible college professor and president, long-time pastor, and is involved currently in writing as well as speaking at Bible conferences. Ron, welcome to Search the Scripture 24/7.Ron: Oh, thank you very much. I consider it a great privilege to be with you all.Tom: Thanks, Gary. Our guest again is Ron Merryman. He's the…well, he's an author, former Bible college professor and president, and longtime pastor, and is currently involved with writing as well as speaking at Bible conferences. Ron's website is merrymanministries.org.Ron, before we get onto where we left off last week, I've got a question for you: didn't you say that your mom and dad were Czechoslovakian?Ron: My mother came from Czechoslovakia, an immigrant family—both her parents were from Czechoslovakia. My father was not. My father had a long history in his family [of] generations in the United States. They came to Virginia colony very early on in the 1600s.Tom: Yeah. Well, the reason I bring that up is because I guess I misunderstood you last week. I was saying, “So Ron, where did the name ‘Merryman' come from?' [laughing] It's a terrific name…Bitchute: https://www.bitchute.com/thebereancall/Brighteon: https://www.brighteon.com/channels/thebereancallGab: https://tv.gab.com/channel/TheBereanCallRumble: https://rumble.com/user/thebereancallOdysee: https://odysee.com/@TheBereanCallVimeo: https://vimeo.com/thebereancallYoutube: https://www.youtube.com/user/TheBereanCall/videosFacebook: https://www.facebook.com/thebereancall/Freetalk45: https://freetalk.app/thebereancallGab: https://gab.com/TheBereanCallGettr: https://gettr.com/user/thebereancallInstagram: https://www.instagram.com/thebereancall/Mewe: https://mewe.com/i/thebereancallParler: https://parler.com/profile/thebereancallTwitter: https://twitter.com/thebereancall
https://www.thebereancall.org/content/t-mcmahon-ron-merryman-part-1More topics on our website: https://www.thebereancall.org/topicsFree eBooks: https://davehunt.orgDownload our app: https://www.thebereancall.org/appFollow us on Social Media: https://www.thebereancall.org/socialTom: Thanks, Gary. Today, my guest is Ron Merryman. Ron is an author, former Bible college professor and president, long-time pastor, and is involved currently in writing as well as speaking at Bible conferences. Ron, welcome to Search the Scripture 24/7.Ron: Oh, thank you very much. I consider it a great privilege to be with you all.Tom: We offer many of Ron's works, including Galatians: God's Antidote to Legalism, Learning from Habakkuk: Discovering Certainty in Times of Uncertainty, and Understanding James 2:14-26: Removing the Theological Tension Between Faith and Good Works. Ron, those books, as well as others that I have by you, I believe are of great value for the body of Christ, because they deal with misunderstandings of essential doctrines that are creating all kinds of problems for believers today. For example, your book on James, James' epistle, that address the difference between faith and good works is terribly important in my view, because the most common error among those who profess to be Christians is works-salvation. Now, give us some background in what motivated you to start writing such books.Bitchute: https://www.bitchute.com/thebereancall/Brighteon: https://www.brighteon.com/channels/thebereancallGab: https://tv.gab.com/channel/TheBereanCallRumble: https://rumble.com/user/thebereancallOdysee: https://odysee.com/@TheBereanCallVimeo: https://vimeo.com/thebereancallYoutube: https://www.youtube.com/user/TheBereanCall/videosFacebook: https://www.facebook.com/thebereancall/Freetalk45: https://freetalk.app/thebereancallGab: https://gab.com/TheBereanCallGettr: https://gettr.com/user/thebereancallInstagram: https://www.instagram.com/thebereancall/Mewe: https://mewe.com/i/thebereancallParler: https://parler.com/profile/thebereancallTwitter: https://twitter.com/thebereancall
Jami and Kait chat about Kait's spiritual journey and how it began with a curiosity about astrology and Human Design and has blossomed into a thriving business! They also touch on the retrogrades that are flying around right now that have been with us for a bit now, and how to use them. Kait founded Kait Merryman Art to help fellow spiritual business owners like reiki masters, astrologers, hypnotists, and other spiritual practitioners navigate the complexities of building a beautiful, unique, and successful brand. After leaving her unfulfilling corporate design job, she turned to astrology as a means of navigating her own career and life path. Over years of studying astrology and human design, and learning the complexities of her energetic strengths and weaknesses she knew it was time to take the leap. Kait Merryman Art was born with a mission to help business owners out there curate their perfect brand through fun, strategic, and eccentric design & illustration. Learn more about Kait at her website: https://kaitmerrymanart.com/ Kait's Socials https://www.tiktok.com/@kaitmerrymanart?lang=en https://www.instagram.com/kaitmerrymanart/ https://www.youtube.com/channel/UCvHtxCePdxTXuZLZ9BcmRaw https://www.facebook.com/kaitlynmerrymanart
Epcoritamab, a bispecific CD20-directed CD3 T-cell engager, is currently being investigated in numerous settings for patients with non-Hodgkin lymphomas. Recently, results were presented at the European Hematology Association (EHA) Congress for Cohorts 2A and 2B of the phase 1/2 EPCORE NHL-2 trial, which is investigating an epcoritamab combination for patients with relapsed/refractory follicular lymphoma. In this interview, Dr. Reid Merryman, an Attending Physician at Dana-Farber Cancer Center and one of the study's investigators, discusses the significance of these results and the efficacy of epcoritamab across the various tumor types being studied.
Drs. John Sweetenham and Marc Braunstein discuss advances in hematologic malignancies featured at the 2023 ASCO Annual Meeting, including the potentially practice-changing SWOG-S1826 study in Hodgkin lymphoma, the promise of bispecific antibodies in B-cell malignancies, and a novel approach to deliver vital anti-myeloma medications that could improve patient quality of life and alleviate barriers to care. TRANSCRIPT Dr. John Sweetenham: Hello, I'm John Sweetenham, the associate director for cancer network clinical affairs at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center and the host of the ASCO Daily News Podcast. The 2023 ASCO Annual Meeting featured some exciting new data on hematologic malignancies. I'm delighted to have Dr. Marc Braunstein return to the podcast to discuss some of these potentially practice-changing studies and new approaches in the heme space. Dr. Braunstein is a hematologist and oncologist at the NYU Perlmutter Cancer Center. You'll find our full disclosures in the transcript of this episode, and disclosures of all guests on the ASCO Daily News Podcast are available on our transcripts at asco.org/DNpod. Marc, it's great to have you back on the podcast, and thanks for being here again. Dr. Marc Braunstein: Thank you, John. It's great to be back. Dr. John Sweetenham: Marc, we already mentioned that there are some potentially practice-changing studies that were reported at ASCO this year. And among those, LBA4, which was presented in the Plenary Session, was a study which explored the treatment of advanced Hodgkin lymphoma. This was the Southwest Oncology Group study S1826. Could you give us your insights on this? Dr. Marc Braunstein: Sure, happy to discuss S1826. So as background, you know, the ECHELON-1 study, which was published in the New England Journal of Medicine in 2022 showed a 40% decrease in the risk of death at six years follow-up by adding brentuximab to AVD compared to bleomycin AVD. And that was in high risk or advanced-stage patients and that led to adoption of brentuximab for upfront use in patients with classical Hodgkin lymphoma in advanced stage. Also of note, immune checkpoint inhibitors such as pembrolizumab or nivolumab do have activity in the relapse setting. The SWOG S1826 study was a randomized control study looking at the use of the PD-1 inhibitor nivolumab plus AVD versus brentuximab AVD in patients with advanced stage classical Hodgkin lymphoma who are at least twelve years of age. And the primary endpoint in the study was progression-free survival. It was a large study which enrolled 976 patients and randomized them one to one to either nivo AVD or brentuximab AVD. The median age in the study was 27 and the median follow-up was 12 months. And what the study found, which could be practice-changing, was that the primary endpoint of progression-free survival was superior in the nivolumab arm with a hazard ratio of 0.8 and a one-year PFS of 94% versus 86%, favoring the nivolumab arm. And while there were side effects associated with the class of medications, for example, hypo or hyperthyroidism was more frequent in the nivolumab group, whereas peripheral neuropathy was higher in the brentuximab group, I think that these results are particularly encouraging for how we can continue to improve outcomes for patients with advanced-stage classical Hodgkin lymphoma. And this may be practice-changing in terms of whether we use upfront immune checkpoint inhibitors in combination with our standard chemotherapy backbone. Dr. John Sweetenham: Yeah, absolutely. There are a couple of things that occur to me. One in particular which is unique about this study, and the fact that it was for patients who are 12 years and older in many respects represents a first because I can't think of another large, randomized study of this type which has attempted to align pediatric and adult care of patients with Hodgkin lymphoma. So, I think it's something of a landmark in that regard. I don't know if you'd agree with that. Dr. Marc Braunstein: I agree, especially with the range of ages from 12 to 83. It's a pretty broad population by age, but I agree it does kind of reconcile those two groups in a disease that has a bimodal presentation and clearly shows that immune checkpoint inhibitors are both potent and well tolerated in different age groups. Dr. John Sweetenham: The other question that I have about this study is we haven't seen so far in this study an overall survival benefit to the nivo arm, which is maybe not surprising, but in terms of the practice-changing potential of this study, do you think that will matter? Dr. Marc Braunstein: I think that's an excellent question, John. Initially, the ECHELON-1 study only showed progression-free survival, and then the update did show overall survival. And so if we take the lead from that study, we expect to see an overall survival benefit in the SWOG study as well with nivolumab, but it remains to be seen. But I think that the data presented thus far at the Plenary Session is compelling enough to consider using nivolumab upfront. Dr. John Sweetenham: Yeah, I absolutely agree. And then I guess the other question that we're going to have to wait probably several years to know is what happens in terms of relapse? So, for the minority of these patients who do relapse, how salvageable, if that's the right word, are they going to be with a second- or third-line regimen? But I think that's clearly something for the future, and it's a very interesting, exciting outcome from this study. Dr. Marc Braunstein: Absolutely. Dr. John Sweetenham: Let's move on. Marc, again, we're still in the lymphoma world here, but looking at high-risk follicular lymphoma. And this was Abstract 7506, looking at epcoritamab plus the R2 regimen in patients with follicular lymphoma. Could you walk us through this one? Dr. Marc Braunstein: Yeah, absolutely. Bispecific T-cell engaging antibodies are showing impressive efficacy in relapsed and refractory non-Hodgkin lymphoma. Epcoritamab is a bispecific antibody that binds to CD3 on T-cells and CD20 B-cells. And this antibody is currently approved for diffuse large B-cell lymphoma patients after two or more prior lines of treatment. In this study presented by Merryman and colleagues, they explored the addition of epcoritamab to standard lenalidomide-rituximab. In 109 patients with relapsed or refractory follicular lymphoma who had at least one prior therapy, and, of note, the study was enriched for high-risk patients for progression, including those who had progression of disease within 24 months of their initial treatment and those patients who had been refractory to prior anti-CD20 treatment. This study enrolled 109 patients with relapsed refractory follicular lymphoma. The median age was 65 and 56% of patients had FLIPI scores on the higher end of the spectrum from three to five, and 61% had stage 4 disease. Also of note, 38% of patients had progression of disease within 24 months of their prior treatment. So at a median follow-up of 8.8 months, the overall response rate was impressive at 97%, and 82% of patients were still on treatment at that time. Now, of course, with this mechanism of action of bispecific antibodies, there is a risk of both cytokine release syndrome and immune-related neurotoxicity. The rates of CRS were primarily low grade, there were only 2% grade 3, and of note, most occurred after the first dose. And in terms of ICANS or neurological toxicity, there were no grade 3 adverse events, and those occurred in only two patients. Finally, the estimated six months progression-free survival was 93%. So, if we cross-compare these results historically to the R-squared regimen, which was published to be about 80%, just cross comparing, so it's not exactly the same study, this clearly shows high activity on par or better with R-squared alone. Although this study was not a randomized study, I think the addition of epcoritamab certainly shows high overall response rates and we'll need randomized data to confirm the efficacy, but it's definitely encouraging in high-risk follicular lymphoma patients. Dr. John Sweetenham: Thanks, Marc. I agree. I think these data are really enticing, in as much as the response rates are so high, but of course, it is follicular lymphoma, so we'll have to wait a while. But the thing that it does make me reflect on is that bispecific antibodies really are turning out to be remarkably effective in a range of B cell malignancies, so, it's very interesting to continue to watch this space. I'm going to change gears now and talk about something completely different for a moment. And this was Abstract 1536. I think that many of us are in a position where we're now looking at how we deliver our clinical services, and particularly inpatient services, to patients with hematologic malignancy. And this study addressed that very specifically. Can I have your thoughts on that? Dr. Marc Braunstein: Sure. In the context of how our therapies are improving, our approaches to how we manage patients clinically is changing too, in many ways for the better. So, various models exist for, you know, which practitioners manage oncology patients who happen to be admitted to the hospital. This abstract, which was performed by authors at a large medical center in New York, describes the use of a dedicated hematologic malignancy hospitalist for managing medicine-related issues. And the authors did comparisons of that service to a service primarily managed by oncologists. The authors compared things such as length of stay, whether the patients were discharged by noon, which is a hospital metric that's used for facilitating turnover of patients and space availability, as well as 30-day readmission rates among patients cared for by an oncology attending versus this heme malignancy hospitalist between July of 2021 and July 2022. The outcomes showed that admissions to the heme malignancy hospitalists were, although less because that service was primarily for patients who required medicine-related issues as opposed to primarily oncologic issues, there were 95 admissions to that service versus 669 to the oncology service. There was a significantly shorter length of stay on the heme malignancies hospitalist service by about 2 to 5 days compared to the oncology hospitalist service. The rates of patients who were discharged by noon or the length of stay were similar between the two groups. So, while this study is confounded by differences in acuity of disease between the services, using a dedicated heme malignancy hospitalist has many benefits, not just to offload the oncology-managed service, which may have a higher level of acuity, but also allow for a deviation of care for medicine-specific issues, to a hospitalist that's specifically trained in managing patients with hematologic malignancies and then dedicating the oncology specialty service to those who need acute oncologic care, such as those with leukemia or other high acuity diseases. Dr. John Sweetenham: Thanks, Marc. I think it is really interesting to see some outcome data for this model of care. A number of centers I know are looking at an APP-led inpatient service for these types of patients, too, so it's going to be very interesting to see how further studies of these kinds of approaches continue to develop. And on a related theme of changes in patterns of care, Abstract TPS1609 looked at home infusion and of course, this is something that really started to attract a lot more attention during the COVID-19 pandemic. But I wonder if you could walk us through some of the details of this poster. Dr. Marc Braunstein: This study was presented as a poster proposing a prospective study looking at home infusion of the anti-CD38 monoclonal antibody daratumumab, which has a vital role in managing patients with newly diagnosed or relapsed multiple myeloma. And monoclonal antibodies have really revolutionized the care of patients with multiple myeloma, but often their infusion schedule is weekly or biweekly, and it does require relatively frequent visits to an infusion center. So, this single-arm, open-label study is going to examine whether we can provide home administration of subcutaneous daratumumab and assess whether it improves quality of life and assess its safety. So, in this study, a visiting nurse will come and deliver the medication after patients take their pre-medications at home prior to the arrival of the infusion nurse. And then the investigators will provide quality of life questionnaires prior to and after the infusions and at the end of the study, and they'll be looking at any barriers to adherence, any barriers to the logistics of this home infusion arrangement. And I think that this has a lot of potential not just to improve quality of life, but also to facilitate care to patients who may be frail, who may not have good caregiver support, who may have barriers in traveling to an infusion center or perhaps in places that are more resource-deprived and don't have local infusion centers. This could be a potential approach to delivering vital anti-myeloma medications at home, and I'm looking forward to seeing the results. Dr. John Sweetenham: Yeah, I agree. I think a lot of us still have anxieties about the safety of this approach, but I think there are increasing data to suggest that home infusion is not only safe but also, as you mentioned, is a big enhancer of the quality of life of these patients. And so, very interesting to see how this plays out in prospective studies. So, to close out, I wonder if you could walk us through Abstract 7072, a poster looking at the issue of clonal hematopoiesis. Dr. Marc Braunstein: Clonal hematopoiesis, which is a phenomenon in which the blood cells acquire somatic mutation, is associated with both cardiovascular disease adverse outcomes as well as hematologic malignancy. It's been shown to be a precursor for diseases such as leukemia. So, this relatively small study from MD Anderson Cancer Center examined clonal hematopoiesis in 78 patients with malignancies, 70% of which had a history of cancer, and the authors described outcomes associated with clonal hematopoiesis. So, again, 78 patients were examined, and 76% of them had a history of malignancy, and 73% had other comorbidities. And the authors demonstrated clonal hematopoiesis by the finding of specific mutations in the blood associated with clonal hematopoiesis. The authors essentially looked at outcomes such as mortality. They noted that only 20% of the patients developed a myeloid neoplasm, and that's relevant because, again, clonal hematopoiesis is a precursor for myeloid neoplasms. They also noted that most patients had died from a primary malignancy rather than a myeloid neoplasm, which is not too surprising considering that most patients with clonal hematopoiesis will not develop a hematologic malignancy, but it is a marker for the potential transformation. And so, I think the authors conclude that clonal hematopoiesis is important for monitoring patients who are at risk for potential myeloid transformation and hematologic malignancy, but it's not necessarily the case that patients who have a background of malignancy will often develop a myeloid malignancy. I think there are many implications of clonal hematopoiesis for cancer in general in terms of the risk of secondary malignancies in those treated with adjuvant chemotherapy, in terms of how we monitor patients who actually more and more are going to have this detected as we use more next-generation sequencing and liquid biopsies. So, I look forward to future studies that are exploring how to actually prospectively assess clonal hematopoiesis and use it for clinical stratification for things like adjuvant chemotherapy or monitoring for risks of hematologic malignancy. Dr. John Sweetenham: Thanks, Marc. I agree. Very important for the future, especially as we gain more and more sequencing data. So, Marc, in conclusion, I want to thank you very much for sharing your insights with us today on the ASCO Daily News Podcast. It's been great to talk with you again. Dr. Marc Braunstein: My pleasure. Happy to be back, and I look forward to a future podcast session. Dr. John Sweetenham: And thank you to our listeners for joining us today. You'll find links to the abstracts discussed today in the transcripts of this episode. Finally, if you value the insights that you hear on ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers: Dr. John Sweetenham Dr. Marc Braunstein @docbraunstein Follow ASCO on social media: @ASCO on Twitter ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. John Sweetenham: Consulting or Advisory Role: EMA Wellness Dr. Marc Braunstein: Consulting or Advisory Role: Pfizer, Bristol-Myers Squibb/Celgene, Adaptive Biotechnologies, GlaxoSmithKline, ADC Therapeutics, Janssen Oncology, Abbvie, Guidepoint Global, Epizyme, Sanofi, CTI BioPharma Corp Speakers' Bureau: Janssen Oncology Research Funding (Institution): Janssen, Celgene/BMS
In May 2023, the FDA granted approval to epcoritamab, a CD3-redirecting, CD20-targeting bispecific antibody, for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma. Following the approval, Oncology Data Advisor® spoke with Dr. Reid Merryman, an Attending Physician at Dana-Farber Cancer Institute and one of the investigators of the EPCORE NHL-1 trial, on which the approval was based, to learn more about the efficacy and safety of epcoritamab and its burgeoning role in the treatment of relapsed/refractory DLBCL.
Join Kait Merryman as she interviews her father, Billy Merryman, a long time art director and project manager in the art industry. In this episode, they explore Billy's "art origin story" and discuss his career journey from art direction to project management. They also delve into his personal artwork and creative outlets, including his involvement in pet portrait commissions. Billy shares his insights on the art industry's exciting developments and future prospects, particularly in the field of AI art. Finally, they wrap up the episode with some valuable advice for aspiring artists and industry professionals. Tune in to this insightful and personal conversation about art and creativity. Support Billy Here: https://www.instagram.com/billymerrymanart/ Support the Podcast: https://www.instagram.com/artwisepodcast/ https://linktr.ee/artwisepodcast
Brett is joined in Hour 1 by the new Head Coach of Northrop Boys' Basketball, Shane Merryman! We welcome Shane to the job, and also ask about his history and career so far in basketball, and get his thoughts on what he wants to bring to the Bruins program. We are also joined by NFL Reporter for ESPN, Stephen Holder! Brett gets Stephen's report on how the first look at Colts quarterback Anthony Richardson at a practice went. He also shares with Brett a more in-depth look at Anthony's character as both a player and a person, and how his personality lends to him being a potential leader. We get more of an idea of AR as a person through talking to Stephen. We also hear about the veterans on the Colts team and whether or not they have faith in Richardson to lead the team to victory. All that and more in Hour 1 of The Sports Rush!See omnystudio.com/listener for privacy information.
Spring practice is over, but there's still plenty of activity going on at Merryman. Pete and Robbie get you up to date on all the latest football news before welcoming Arash Tafakor from Downtown Crown and Dominion Wine & Beer to talk about the beer industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
Daily Quote The best physicians are Dr. Diet, Dr. Quiet and Dr. Merryman. (Jonathan Swift) Poem of the Day Song Of The Flower Khalil Gibran Beauty of Words 就像人每天必须吃饭一样 季羡林
Guest: Dr. Pam Merryman, PCA US English teacher Pam and her sister were the first two students enrolled in First Baptist Academy in Dallas, TX. She not only graduated from First Academy, she became the first alumni to return and teach there as well. “I never demand any more of my students than I'm willing to give myself.” Dr. Merryman Dr. Merryman was the force behind bringing Capstone to PCA. Capstone is a senior project of three different papers around one particular literary piece. Seniors write a philosophical paper, an historical paper, and a literary analysis of a book that they choose. Then, the final piece, is looking at the book through a Biblical worldview, the lens of God's Word, and in light of the five pillars of the Portrait of a PCA Graduate and what they've learned in their time at PCA. Portrait of a PCA Graduate: Reverence For God An Eternal Perspective Christ-like Humility Scholastic Excellence Critical Thinking Remember my affliction and my wanderings, the wormwood and the gall! My soul continually remembers it and is bowed down within me. But this I call to mind, and therefore I have hope: The steadfast love of the Lord never ceases; his mercies never come to an end; they are new every morning; great is your faithfulness. Lamentations 3:19-23 Special shout out to Jared Wood for allowing us to use his music - check him out at JaredWoodMusic!
Daily Quote The best physicians are Dr. Diet, Dr. Quiet and Dr. Merryman. (Jonathan Swift) Poem of the Day Song Of The Flower Khalil Gibran Beauty of Words 就像人每天必须吃饭一样 季羡林
Ashley Merryman (www.AshleyMerryman.com) changes the world's dialogue. She finds the science essential to understanding what makes people tick—what motivates us, what inspires us—from individual quirks to institutional phenomena. Then she explains how to use these insights to transform our lives. The best place to get them is to subscribe to her newly reborn newsletter www.thesherwoodreport.com Her book NurtureShock, co-authored with Po Bronson, has become one of the most influential books about children ever published. On the New York Times bestseller list for more than six months and an Amazon Top Nonfiction 100 book for over a year, it has been translated into 20 languages. Their follow-up, Top Dog: The Science of Winning and Losing, was another instant New York Times bestseller with foreign translations around the world. Since its publication, Top Dog has revolutionized the world of elite performance. Coaches of professional sports carry it in their bags. Olympians have described themselves as "Top Dog athletes." In addition to cover stories and more for Newsweek and New York, Merryman has had bylines in the New York Times, Time, the Washington Post, CNN.com, the Guardian, ESPN Magazine, and others. Her media appearances include: CNN's Anderson Cooper 360; Fox and Friends; CBS This Morning; @KatieCouric; John Stossel; ESPN's Outside the Lines; HBO's Real Sports with Bryant Gumbel; Red Bull's Visions of Greatness; BBC's World News and Sports Hour; and NPR's On Point. She is also a contributor to Chronicle Books' bestselling 642 Things to Write About. (And she once delighted "Mr. Wonderful" Kevin O'Leary with an on-air explanation of how science could predict his success, while Stephen Colbert devoted a segment of The Colbert Report to her take on kids and competition.) REGISTER NOW! The 2023 Way of Champions Conference will be held August 4-6, 2023 at Colorado Academy in Denver, CO. Click here to learn more and register. You can save $100 until April 1 by entering EARLYBIRD at checkout, as well as get access to the best hotel rooms right across the street from Colorado Academy. Its going to be amazing to be back in person in 2023! This week's podcast is brought to you by our friends at Sprocket Sports. Sprocket Sports is a new software platform for youth sports clubs. There are a lot of these systems out there, but Sprocket provides the full enchilada. They give you all the cool front-end stuff to make your club look good– like websites and marketing tools – AND all the back-end transactions and services to run your business better so you can focus on what really matters – your players and your teams. Sprocket is built for those clubs looking to thrive, not just survive, in the competitive world of youth sports clubs. So if you've been looking for a true business partner – not just another app – check them out today at https://sprocketsports.me/CTG. Become a Podcast Champion! This weeks podcast is also sponsored by our Patreon Podcast Champions. Help Support the Podcast and get FREE access to our most popular online courses, a $300 value. If you love the podcast, we would love for you to become a Podcast Champion, (https://www.patreon.com/wayofchampions) for as little as a cup of coffee per month (OK, its a Venti Mocha), to help us up the ante and provide even better interviews, better sound, and an overall enhanced experience. Plus, as a $10 per month Podcast Super-Champion, you will have access to never before released and bonus material, including: Downloadable transcripts of our best podcasts, so you don't have to crash your car trying to take notes! A code to get free access to our online course called "Coaching Mastery," usually a $97 course, plus four other courses worth over $100, all yours for free for becoming a patron. Other special bonus opportunities that come up time to time Access to an online community of coaches like you who are dedicated listeners of the podcast, and will be able to answer your questions and share their coaching experiences. Thank you for all your support these past four years, and a special big thank you to all of you who become part of our inner circle, our patrons, who will enable us to take our podcast to the next level. https://www.patreon.com/wayofchampions
Ashley Merryman (www.AshleyMerryman.com) changes the world's dialogue. She finds the science essential to understanding what makes people tick—what motivates us, what inspires us—from individual quirks to institutional phenomena. Then she explains how to use these insights to transform our lives. The best place to get them is to subscribe to her newly reborn newsletter www.thesherwoodreport.com Her book NurtureShock, co-authored with Po Bronson, has become one of the most influential books about children ever published. On the New York Times bestseller list for more than six months and an Amazon Top Nonfiction 100 book for over a year, it has been translated into 20 languages. Their follow-up, Top Dog: The Science of Winning and Losing, was another instant New York Times bestseller with foreign translations around the world. Since its publication, Top Dog has revolutionized the world of elite performance. Coaches of professional sports carry it in their bags. Olympians have described themselves as “Top Dog athletes.” In addition to cover stories and more for Newsweek and New York, Merryman has had bylines in the New York Times, Time, the Washington Post, CNN.com, the Guardian, ESPN Magazine, and others. Her media appearances include: CNN's Anderson Cooper 360; Fox and Friends; CBS This Morning; @KatieCouric; John Stossel; ESPN's Outside the Lines; HBO's Real Sports with Bryant Gumbel; Red Bull's Visions of Greatness; BBC's World News and Sports Hour; and NPR's On Point. She is also a contributor to Chronicle Books' bestselling 642 Things to Write About. (And she once delighted “Mr. Wonderful” Kevin O'Leary with an on-air explanation of how science could predict his success, while Stephen Colbert devoted a segment of The Colbert Report to her take on kids and competition.) REGISTER NOW! The 2023 Way of Champions Conference will be held August 4-6, 2023 at Colorado Academy in Denver, CO. Click here to learn more and register. You can save $100 until April 1 by entering EARLYBIRD at checkout, as well as get access to the best hotel rooms right across the street from Colorado Academy. Its going to be amazing to be back in person in 2023! This week's podcast is brought to you by our friends at Sprocket Sports. Sprocket Sports is a new software platform for youth sports clubs. There are a lot of these systems out there, but Sprocket provides the full enchilada. They give you all the cool front-end stuff to make your club look good– like websites and marketing tools – AND all the back-end transactions and services to run your business better so you can focus on what really matters – your players and your teams. Sprocket is built for those clubs looking to thrive, not just survive, in the competitive world of youth sports clubs. So if you've been looking for a true business partner – not just another app – check them out today at https://sprocketsports.me/CTG. Become a Podcast Champion! This weeks podcast is also sponsored by our Patreon Podcast Champions. Help Support the Podcast and get FREE access to our most popular online courses, a $300 value. If you love the podcast, we would love for you to become a Podcast Champion, (https://www.patreon.com/wayofchampions) for as little as a cup of coffee per month (OK, its a Venti Mocha), to help us up the ante and provide even better interviews, better sound, and an overall enhanced experience. Plus, as a $10 per month Podcast Super-Champion, you will have access to never before released and bonus material, including: Downloadable transcripts of our best podcasts, so you don't have to crash your car trying to take notes! A code to get free access to our online course called “Coaching Mastery,” usually a $97 course, plus four other courses worth over $100, all yours for free for becoming a patron. Other special bonus opportunities that come up time to time Access to an online community of coaches like you who are dedicated listeners of the podcast, and will be able to answer your questions and share their coaching experiences. Thank you for all your support these past four years, and a special big thank you to all of you who become part of our inner circle, our patrons, who will enable us to take our podcast to the next level. https://www.patreon.com/wayofchampions
This episode has been the cursed episode with a re-record due to poor sound quality, Andrew "getting in a car accident" (popping a tire) on the way to the first recording, our Guest Bartender, Mike Merryman, cut the tip of his pinky finger off making the drinks during the second recording and this is the longest episode 2G1C has ever put out ... but this is one of our best episodes yet! Just like the Trinidad Sour, this journey has been full of bitters, but unlike the Trinidad Sour, our outcome is enjoyable and fun. Thank you to the Trini-Daddy Mike Merryman for agreeing to do this again. Recipe: Trinidad Sour Liquor.com recipe • 1 1/2 ounces Angostura bitters • ½ ounce Rye Whiskey • ¾ ounces Lemon Juice, Freshly Squeezed • 1 ounce Orgeat • Garnish with a Lemon Twist Preparation: 1. Add the Angostura bitters, rye whiskey, lemon juice, and orgeat into shaker with ice and shake until well-chilled. 2. Double-strain into chilled Nick & Nora glass. 3. Garnish with a Lemon twist. ℂ
With winter workouts in full swing, it's been busy in Merryman as of late. The recent position coach departures added to the frenzy of activity, throwing some fans for a loop. Pete and Robbie break down all the latest news and notes in an effort to get you ready for Spring football. Learn more about your ad choices. Visit megaphone.fm/adchoices
“As an Aries rising, we're very independent and we don't like taking orders from other people, and after studying astrology for a while and looking at my own chart, especially with my Capricorn midheaven, I realized I need to start my own business.”Graphic artist, illustrator and “Art-wise” podcast host Kait Merryman joins the show to discuss using Astrology and Human Design to navigate your career path. After her spiritual awakening, Kait left her corporate dream job to start her own graphic design business. She credits Astrology and Human Design for helping her take the leap-of-faith. In this episode, Kait shares the spiritual awakening that led to her journey from employee to CEO, the process of decoding birth and human design charts and the trials and triumphs of an early entrepreneur.Connect with Kait:Website: kaitmerrymanart.comInstagram: @kaitmerrymanart Podcast: Art-WiseThis episode is brought to you by Magic Mind– the world's first productivity shot. Magic Mind is made with matcha to boost your energy, adaptogens to help you relax, nootropics to help you focus and agave to sweeten the taste. Visit MagicMind.co/astrocandy and use the discount code ASTROCANDY to get up to 56% off your first subscription in the next 10 days or 20% off your first one-time purchase.About Astrocandy:Host Raven Brinson invites you on a mission of self-exploration and discovery through spiritual and mystical topics like astrology, holistic healing and wellness, manifestation, mindfulness and meditation, human design, chakra balancing and more.Connect with Astrocandy: Website: astrocandypodcast.comInstagram: @astrocandypodcast
We are talking with Caroline about her business for the third time, but it's an interesting business and it's fun getting the updates on how things are going. Feel free to listen in, watch, and comment! — The Tea Podcast is proudly sponsored by The Music Academy of Acadiana. The Music Academy of Acadiana is Acadiana's top choice for music lessons in piano, guitar, voice, drums, violin, saxophone, flute, audio production & more. They teach students of all ages and styles, they have sent students to college, to compete in major music competitions, and have also premiered on major TV Music contests like American Idol & The Voice. Founded by University of Louisiana at Lafayette music school graduate Tim Benson, the Academy has been voted as a top finalist in the best music school by readers of the Times since 2016 and they have won the national music school of the year award in 2014. Their goal is to make music lessons fun, educational and to help foster the next generation of musicians and creative thinkers! You can find them at the following links: Website: https://www.musicacademyacadiana.com Facebook: https://www.facebook.com/MusicAcademy... — The Tea Podcast is part of the https://acadianacasts.com podcasts network. --- Send in a voice message: https://anchor.fm/the-tea-podcast/message Support this podcast: https://anchor.fm/the-tea-podcast/support
On the Jan. 5 "Friday LIVE Extra" podcast, a look at events at the Merryman Center in Kearney and The National Willa Cather Center in Red Cloud. By the way, the Midwest Theater in Scottsbluff also welcomes Dailey & Vincent for a concert.
On the Jan. 5 "Friday LIVE Extra" podcast, a look at events at the Merryman Center in Kearney and The National Willa Cather Center in Red Cloud. By the way, the Midwest Theater in Scottsbluff also welcomes Dailey & Vincent for a concert.
Acacia is joined by Keeneland's Vice President of Sales, Tony Lacy, to recap the November Sales and all that has been happening at Keeneland lately. She then speaks to Lizzie Merryman, the breeder of Breeders' Cup Turf Sprint winner Caravel.
Acacia is joined by Keeneland's Vice President of Sales, Tony Lacy, to recap the November Sales and all that has been happening at Keeneland lately. She then speaks to Lizzie Merryman, the breeder of Breeders' Cup Turf Sprint winner Caravel.
The Yeomen of the Guard; or, The Merryman and His Maid, is a Savoy Opera, with music by Arthur Sullivan and a libretto by W. S. Gilbert. It premiered at the Savoy Theatre on 3 October 1888 and ran for 423 performances. This was the eleventh collaboration of fourteen between Gilbert and Sullivan.Purchase the music (without talk) at:Gilbert and Sullivan: Yeoman of the Guard (classicalmusicdiscoveries.store)Your purchase helps to support our show! Classical Music Discoveries is sponsored by La Musica International Chamber Music Festival and Uber. @CMDHedgecock#ClassicalMusicDiscoveries #KeepClassicalMusicAlive#LaMusicaFestival #CMDGrandOperaCompanyofVenice #CMDParisPhilharmonicinOrléans#CMDGermanOperaCompanyofBerlin#CMDGrandOperaCompanyofBarcelonaSpain#ClassicalMusicLivesOn#Uber Please consider supporting our show, thank you!Donate (classicalmusicdiscoveries.store) staff@classicalmusicdiscoveries.com
Missionary Ricky Merriman Missions Emphasis Month Sunday, August 7, 2022
The imprisonment of John Merryman at Fort McHenry at the start of the Civil War becomes the foundation for rules of habeus corpus in the United States. See omnystudio.com/listener for privacy information.
The MAP boys sit down with Ashley Merryman, the co-author (along with Po Bronson) of "Top Dog: The Science of Winning and Losing." Their book, "NurtureShock", has become one of the most influential books about children ever published. Both books are New York Times bestsellers. Merryman has written for the NY TImes, Time, the Washington Post, CNN.com, the Guardian, ESPN Magazine, and others. She has made appearances on CNN's Anderson Cooper 360; Fox and Friends; CBS This Morning; ESPN's Outside the Lines; HBO's Real Sports with Bryant GumbelAmong other topics, she discusses the importance of competition in development - difference in types of competitors - the impact TEAM can have on competitors - how the way you set up a competition can have influence on the competitors - difference between genders in competition, etc.To view more from Ashley -- go to her website: www.ashleymerryman.com Questions or comments for the show: podcast@mentaladvantage.netTo contact John Cullen: john.cullen@mentaladvantage.netTo contact Brandon Allen: brandon.allen@mentaladvantage.net
BRM and Pat talk about the headlines around Hokie Sports. Pat interviews Antonio Hazen Cotman Jr. following his visit to Virginia Tech.
Daily Quote The best physicians are Dr. Diet, Dr. Quiet and Dr. Merryman. (Jonathan Swift) Poem of the Day Song Of The Flower Khalil Gibran Beauty of Words 就像人每天必须吃饭一样 季羡林
Merryman, Dumb Bunny, Awkwardman, White Feather and the Blimp! Names that strike fear into the hearts of..... well, nobody really. David and Peter dive into the entertaining world of comedy and DC and Marvel Comics parody as they cover ALL the Silver Age exploits of this team of Legacy heroes. They also pose the vital question, exactly which Earth are these stories set? Tune in to find out! #dccomics #dcu #inferior5 #plasticman #enelsonbridwell #joeorlando #mikesekowsky #jwinslowmortimer #keithgiffen #jefflemire #showcase #dcshowcase #grantmorrison #animalman #captaincarrot #zoocrew #marvelcomics #marvel #parody #notbrandechh
BRM and Pat catch you up on all things Virginia Tech Athletics + Austin Gabel joins the pod to talk Wrestling ahead of the ACC Tournament
We talk with Melanie Martin, DNP, PMHNP, FNP-BC about grief and loss in this episode. We approach the discussion from a number of different directions and even chat about the approach to patient care from the eye of Dr Diet, Dr Quiet and good old Dr Merryman. DR. Martin also shares her personal struggle with a dramatic loss, and how this personal experience has led her to join us in the mental health community. https://blueskymentalhealth.com/provider/ (Melanie Martin), DNP, PMHNP, FNP-BC https://blueskymentalhealth.com/ (Blue Sky Mental Health and Wellness) in Tucson, AZ Contact PsychNP CastWant to be a guest? Fill this form out: https://forms.gle/tTQ8nChFaV4tKEj38 (https://forms.gle/tTQ8nChFaV4tKEj38) Email us Email: PsychNPcast@gmail.com
Drip shares her journey and knowledge about a trip down the rabbit hole of finding capsules that don't leak. Seriously, you want to tune-in as many easy-to-find capsule blanks often crack and leak (and yes, we discuss the dreaded "internal use of essential oils"). Drop recently finished the book “God's Hotel” by Victoria Sweet and shares the concepts of “Viriditas” (vigor, healing) and “Dr. Diet, Dr. Quiet & Dr. Merryman” all within the Galenic tradition of healing the whole person. Thanks to the book and its many references to Hildegard von Bingen, Drop has been smelling Tansy and looking to have some grow in the garden. Similarly, Drip recently planted Monarda fistulosa in her garden, though she seems to be on a never-ending search for its hard-to-come-by essential oil.
Today Co-Hosts, Kendall Heath and Debbie Chisholm, broadcast from Hive Design Stationery Gifts in Gastonia, North Carolina where we get to bask in the golden, honeyed glow of The Hive's Founder, Merryman Cassels. Merryman is one of "those" women; you know the ones! She arrives with stories of sacred pilgrimages, dreams realized and dreams brewing, a buzz of creative life-force swirling around her, and exotic gifts from far-off adventures sparkling in her shaman-starry eyes.She talks about The Hive as being her ministry in the world, as she dredges up the wisdom of The Melissae of Ancient Greece and tells sacred stories of important moments of anointing and connection. She's says, "I love sharing my personal calling from the bee and the powerful ways the hive has stung, taught, and healed me with its guiding love. The hive is a superorganism that is a powerful metaphor for life and our existence as Divine beings. Hive Design in its purest essence is my ministry and our beautifully restored building is the temple." You do NOT want to miss this rich & delicious show with our local (Charotte Metro, NC) High Priestess of Honey!
© 2020-2026 Ivy Podcast Discovery LLC
